Donggeng Liu
About
In The Last Decade
Donggeng Liu
15 papers receiving 340 citations
Peers
Comparison fields: 5 of 49
- Oncology 248
- Pulmonary and Respiratory Medicine 145
- Molecular Biology 118
- Radiology, Nuclear Medicine and Imaging 82
- Cancer Research 70
Countries citing papers authored by Donggeng Liu
This map shows the geographic impact of Donggeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donggeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donggeng Liu more than expected).
Fields of papers citing papers by Donggeng Liu
This network shows the impact of papers produced by Donggeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donggeng Liu. The network helps show where Donggeng Liu may publish in the future.
Co-authorship network of co-authors of Donggeng Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Donggeng Liu. A scholar is included among the top collaborators of Donggeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donggeng Liu. Donggeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 17 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 231 | |
| 8 | 7 | |
| 9 | Efficacy and Safety of Toremifene in Young Patients with Luminal Subtype Early Breast Cancer: A Retrospective Study | 1 |
| 10 | 36 | |
| 11 | 5 | |
| 12 | 11 | |
| 13 | [Comparison of cisplatin combined with gemcitabine versus cisplatin combined with vinorelbine regimen for treatment of patients with advanced non-small cell lung cancer]. | 4 |
| 14 | [Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC)]. | 1 |
| 15 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.